Hematology Center
The Hematology Center offers services in diagnosis and treatment of cancer and other diseases related to the blood as well as patients who have received stem cell or bone marrow transplants. The center is staffed by a multidisciplinary medical team under international quality standards such as Hospital Accreditation (HA) and from the Joint Commission International (JCI) from the United States.
The Hematology aims to provide prompt diagnosis and timely treatment by specialized medical staff supported by advanced medical technology. The center prides itself in its specialization in stem cell and bone marrow transplantation and Targeted Therapy, the goal of which is to discover and treat the cause of disease to decrease the negative effects of abnormal cells. The goal is to provide efficient treatment with positive results, prevent recurrence of disease, while minimizing patient expenditure.
Wattanosoth Hospital (Bangkok Cancer Hospital) has offered services in stem cell and bone marrow transplantation since 2008. This treatment is a tertiary care service and has been wide accepted in the international medical community; today it is considered one of the best forms of cancer treatments that prevent recurrence.
At the Hematology Center we treat patients as family, to instill trust and belief in our medical team and treatment methods, all of which are pivotal to ensure cancer treatment is efficient and successful. The team of doctors and nurses will explain clearly to patients and relatives each step of the treatment process. The center offers One Stop Service with Comprehensive Facilities, such that when a patient is registered at Wattanosoth Hospital he/she will not have to be referred to another institution as the hospital will offer all necessary aspects of care under the guidance of specialized doctors and nurses who are on hand 24/7 to provide support and meet patient’s needs.
At Hematology Center Wattanosoth Cancer Hospital our diagnostic and treatment services include the following diseases
1. Hematologic Malignancy
2. Blood Disorder
- Anemia
- Thalassemia -a genetic disease
- Aplastic Anemia
3. Other disease related to blood
- Anemia from other causes such as kidney failure
- Low blood platelet count – Thrombocytopenia
- Abnormal blood conditions- i.e. excessive bleeding that does not stop
Blood and Marrow Stem Cell Transplant Center aims to provide a holistic care for patients with hematologic malignancies and bone marrow disorders such as aplastic anemia and thalassemia with severe symptoms. Since technological development has increasingly emerged, medical technology along with expertise significantly improves the chance of success rates. Before starting treatment, treatment options will be thoroughly explained to the patients and family, therefore treatment plans could be mutually customized depending primarily on patient’s conditions and desires while taking both physical and mental aspects into consideration. Not only improving survival, but our comprehensive care also intends to enhance patient’s quality of life during and after treatment.
Our Superiority
- Advanced sterilization room with positive pressure: To reduce the chance of infections during treatment, patients will be treated in isolation rooms with special air filters.
- Well-trained and highly specialized hematologists in all types of bone marrow transplant, including autologous transplant (self-donated), allogeneic transplant using matched donor and haploidentical transplant (allogeneic transplant using half-matched donor).
Our Services
Comprehensive services at Blood and Marrow Stem Cell Transplant Center include:
- Hematologic malignancies
- Leukemia
- Lymphoma
- Multiple myeloma
- Myelodysplastic syndrome (MDS)
- Non-malignant blood disorders
- Thalassemia
- Aplastic anemia
Advances in technology and treatment approaches
Bone marrow and stem cell transplants are effective methods used to treat hematologic malignancies e.g. leukemia, multiple myeloma and non-Hodgkin’s lymphoma. Transplantation, considered as new hope of a cure, helps restoring the body’s ability to produce new blood cells after achieving complete remission by the administration of high-dose chemotherapy and/or radiation. Besides attaining the best possible treatment outcomes, our highly experienced hematologists have expertise in monitoring and managing graft versus host disease (GVHD) which is an immune-mediated condition resulting from a complex interaction between donor and recipient adaptive immunity. Effective management significantly reduces the chances of failure and mortality rates. As a result, the chances of being cured from blood cancers are considerably high, especially in patients who received timely treatment.
Before starting treatment
Prior to bone marrow and stem cell transplant, patients need to undergo a series of tests and procedures to assess their general health and the status of their conditions in order to ensure that they are physically prepared for the transplant. More importantly, patients need to understand their requirement for the transplant as well as all processes of treatments and expected outcomes. Possible side effects and complications caused by the transplant might arise at anytime during treatment. These often include infections due to suppressed immune function, side effects or adverse drug reactions from high-dose chemotherapy and graft versus host disease which is a possible complication of receiving a stem cell or bone marrow transplant from another person (an allogeneic transplant). Therefore, close supervision and appropriate management of these undesired effects remain extremely important.
Important Notice
A series of laboratory tests and procedures is involved during treatment in order to ensure that patients are physically eligible for receiving high-dose chemotherapy as a part of the transplant with less chances of complications. Patients’ conditions must be applicable to remain in the sterilization rooms to continue treatment for a month or even longer in some cases.